Drug Trials Snapshots: INPEFA (sotagliflozin)

INPEFA is a drug that reduces the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults with: heart failure or type 2 diabetes mellitus, chronic kidney disease, and other cardiovascular risk factors https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-inpefa